Tuan Tu Diep is Chief Development Officer at Skye Bioscience, Inc. (SKYE). They have made 1 open-market trade across 1 company since 2024, most recently 2024-11-18.
CIK 0002013809
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SKYE | 82,259 | $128K |
Shares reported on the most recent Form 4, priced at the 2024-11-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SKYE | SELL | 2024-11-15 | 2024-11-20 | $4.99 | $195K | +2.3% | -37.4% | -27.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.